Brief: Rakuten Medical: Closes $119 Million Series E Financing To Develop Alluminox™ Platform, Including $45 Million In New Capital And Conversion Of $74 Million Of Convertible Promissory Notes With Accrued Interest

Daiichi Life

07/03/2024 01:52

March 7 (Reuters) - Rakuten Group Inc  4755.T :
    * RAKUTEN MEDICAL: CLOSES $119 MILLION SERIES E FINANCING TO
DEVELOP ALLUMINOX™ PLATFORM, INCLUDING $45 MILLION IN NEW
CAPITAL AND CONVERSION OF $74 MILLION OF CONVERTIBLE PROMISSORY
NOTES WITH ACCRUED INTEREST
    * RAKUTEN MEDICAL: SERIES E INVESTORS INCLUDE UK-BASED
PHARMACEUTICAL COMPANY HIKMA, MIZUHO BANK, DAI-ICHI LIFE, SBI
GROUP, RAKUTEN GROUP AND ITS CEO MIKITANI

Source text: https://rakuten-med.com/us/news/press-releases/2024/03/06/7827/
Further company coverage:  4755.T 

 (Reporting by Kantaro Komiya)
 ((Kantaro.Komiya@thomsonreuters.com;))